Side-by-side comparison of AI visibility scores, market position, and capabilities
Global investment bank and wealth manager with $61.9B FY2024 revenue; $7.5T client assets; E*Trade ($13B, 2020) and Eaton Vance ($7B, 2021) acquisitions anchored shift to 55% fee-based wealth revenue.
Morgan Stanley is a leading global financial services firm providing investment banking, securities, wealth management, and investment management services, founded in 1935 by Henry Sturgis Morgan (grandson of J.P. Morgan) and Harold Stanley after breaking away from J.P. Morgan & Co. following the Glass-Steagall Act separation of commercial and investment banking. Headquartered in New York City and trading on NYSE (MS), the company reported approximately $61.9 billion in net revenues for FY2024 under CEO Ted Pick, who succeeded the transformative James Gorman as CEO in January 2024. Gorman's decade-long strategy—shifting Morgan Stanley's revenue mix from volatile investment banking and trading toward stable fee-based wealth management—has resulted in the Wealth Management segment representing approximately 55% of net revenues, with $7.5 trillion in total client assets managed across 15,000+ financial advisors.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.